Literature DB >> 25740707

Isolation and characterization of PDT-resistant cancer cells.

Alicia Zamarrón1, Silvia R Lucena, Nerea Salazar, Francisco Sanz-Rodríguez, Pedro Jaén, Yolanda Gilaberte, Salvador González, Ángeles Juarranz.   

Abstract

Even though the efficacy of photodynamic therapy (PDT) for treating premalignant and malignant lesions has been demonstrated, resistant tumor cells to this therapy occasionally appear. Here, we describe the published methods to isolate resistant cancer cells to PDT and propose new procedures that may be used, as laboratory models allow a better understanding of resistance mechanisms. For this purpose, the treatment conditions, the photosensitizer (PS) or pro-drug, the cell line and the final selection - clonal of total population - must be taken into account. In general, high and repeated treatment doses are used. The resistant cell population characterization may include cell morphology, response to PDT, expression of death proteins or survival related genes and cell proliferation analysis. In addition, in vivo models such as the resistant cell transplantation to mice, allow evaluating tumorigenicity and aggressiveness, leading to the determination of the in vivo resistance. Summarizing, in order to improve clinical results, cellular models can help understand PDT-resistance mechanisms in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25740707     DOI: 10.1039/c4pp00448e

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  8 in total

Review 1.  Which cell death modality wins the contest for photodynamic therapy of cancer?

Authors:  Maria Vedunova; Dmitri V Krysko; Tatiana Mishchenko; Irina Balalaeva; Anastasia Gorokhova
Journal:  Cell Death Dis       Date:  2022-05-13       Impact factor: 9.685

2.  Glycol porphyrin derivatives and temoporfin elicit resistance to photodynamic therapy by different mechanisms.

Authors:  Jarmila Kralova; Michal Kolar; Michal Kahle; Jaroslav Truksa; Sandra Lettlova; Kamila Balusikova; Petr Bartunek
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

3.  Establishment and characterization of human osteosarcoma cells resistant to pyropheophorbide-α methyl ester-mediated photodynamic therapy.

Authors:  Yong Tao; Yunsheng Ou; Hang Yin; Yanyang Chen; Shenxi Zhong; Yongjian Gao; Zenghui Zhao; Bin He; Qiu Huang; Qianxing Deng
Journal:  Int J Oncol       Date:  2017-09-27       Impact factor: 5.650

4.  Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy.

Authors:  Silvia Rocio Lucena; Alicia Zamarrón; Elisa Carrasco; Miguel Angel Marigil; Marta Mascaraque; Montserrat Fernández-Guarino; Yolanda Gilaberte; Salvador González; Angeles Juarranz
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

Review 5.  Autophagy Regulation and Photodynamic Therapy: Insights to Improve Outcomes of Cancer Treatment.

Authors:  Waleska K Martins; Renata Belotto; Maryana N Silva; Daniel Grasso; Maynne D Suriani; Tayná S Lavor; Rosangela Itri; Mauricio S Baptista; Tayana M Tsubone
Journal:  Front Oncol       Date:  2021-01-20       Impact factor: 6.244

6.  Unveiling Ga(III) phthalocyanine-a different photosensitizer in neuroblastoma cellular model.

Authors:  Carolina Constantin; Andreea-Roxana Lupu; Tudor Emanuel Fertig; Mihaela Gherghiceanu; Sevinci Pop; Rodica-Mariana Ion; Monica Neagu
Journal:  J Cell Mol Med       Date:  2018-11-19       Impact factor: 5.310

7.  Epigallocatechin Gallate Enhances MAL-PDT Cytotoxic Effect on PDT-Resistant Skin Cancer Squamous Cells.

Authors:  Daniela León; Kurt Buchegger; Ramón Silva; Ismael Riquelme; Tamara Viscarra; Bárbara Mora-Lagos; Louise Zanella; Fabiola Schafer; Cristina Kurachi; Juan Carlos Roa; Carmen Ili; Priscilla Brebi
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

Review 8.  Molecular Effectors of Photodynamic Therapy-Mediated Resistance to Cancer Cells.

Authors:  Eric Chekwube Aniogo; Blassan P George; Heidi Abrahamse
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.